The filing is part of a broader pattern of selling by Crosslink affiliates over the past two months. While the proposed amount is small relative to market cap, continued insider selling by a director-affiliated fund warrants monitoring for any change in selling pace or insider sentiment.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Crosslink Crossover Fund VI, L.P., a director and venture investor in Chime Financial, filed a Form 144 notice to sell 60,100 shares of common stock with an approximate market value of $2.06 million. The filing signals intent to sell, though the sale may not be completed. Crosslink entities have been actively selling shares in recent months, with multiple prior sales in September and November 2026.
Key Facts
- Crosslink Crossover Fund VI, L.P. (a director) filed Form 144 to sell 60,100 shares of Chime common stock.
- Estimated proceeds from the proposed sale: $2,064,837.67 based on a price of $34.35 per share.
- The shares were originally acquired on 10/27/2014 via a private acquisition from the issuer.
- Crosslink entities have sold a total of approximately 1,081,935 shares in multiple transactions between September 10 and November 13, 2026.
- The proposed sale is scheduled for 11/16/2026 on Nasdaq.
- Chime's market cap is $12.7 billion; the proposed sale represents about 0.016% of shares outstanding.
Financial Impact
Proposed sale of 60,100 shares valued at ~$2.06 million, representing a small fraction of the company's $12.7B market cap.
Risk Factors
- Form 144 is only an intent to sell; the sale may not be executed.
- Crosslink entities have been consistent sellers in recent months, which could signal reduced conviction or portfolio rebalancing.
- No specific reason for the sale is disclosed in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-011151 |
| Document: 0001950047-26-011151-index.html | 0001950047-26-011151 |
| Document: 0001950047-26-011151.txt | 0001950047-26-011151 |
Track record
39 reports on CHYM
9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +14.85% at T+5 after the Sep 14, 2026 report. 12 of 14 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 17, 2026today 144 Neutral 3/10 Entry $32.98 Now $32.97 −0.03% settles Nov 25
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 3/10 Viewing Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 13, 20264d ago SC 13G/A Neutral 3/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers